News

The Journal of the International AIDS Society is pleased to announce the publication of the special issue “PrEP Implementation Science: State-of-the-Art and Research Agenda”. This timely special issue addresses the wide-ranging issues around the use of oral pre-exposure prophylaxis for the prevention of HIV transmission. Click here to read the supplement    

19 July 2015 (Vancouver, Canada) - The International AIDS Society (IAS) and the U.S. National Institutes of Health (NIH) today announced open application for the fifth round of the $3.6 million research grant programme Creative and Novel Ideas in HIV Research (CNIHR). CNIHR is jointly sponsored by the NIH, the NIH-supported Centers for AIDS Research (CFARs) and the IAS. Since 2010, the CNIHR Grant Programme has awarded more than US$16.1 million to fund 44 highly innovative research projects in t...

The Board and the staff of the International AIDS Society mourn the passing of Alan Brotherton, a global leader in HIV activism, from the earliest days in Australia and working in Asia-Pacific and internationally. The impact of Alan´s role in the fight against HIV and AIDS will be felt forever - he was a fearless champion in the very early days of the disease for those people most affected. Alan chaired People Living With HIV/AIDS NSW and Australia’s National Association of People Living With ...

The Journal of the International AIDS Society is pleased to announce a call for abstracts for a supplement on police, law enforcement and HIV. The aim of this supplement is to explore the positive role that the police can play in the HIV response, and share best practices from those working effectively with police against HIV and discrimination, particularly as it relates to marginalized and at-risk populations. Submit your abstract now (no longer than 350 words) by 30 July 2015. For more infor...

In the 18 April issue of The Lancet, IAS leaders – Chris Beyrer, Linda-Gail Bekker, Anton Pozniak, and Françoise Barré-Sinoussi – call for the world to move faster on PrEP (the open access article is available here). The commentary comes as the IAS is preparing a host of new scientific and implementation data on PrEP and other biomedical prevention efforts at the 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention in Vancouver (IAS 2015). www.ias2015.org.

The Journal of the International AIDS Society is pleased to announce the publication of the abstracts presented at the Congress on HIV Drug Therapy in the Americas, taking place on the 16-18 April 2015, in Mexico City, Mexico. Click here to access the supplement

The Journal of the International AIDS Society is pleased to announce the publication of the special issue “HIV and adolescents: focus on young key populations”. This timely supplement covers the HIV-specific issues encountered by adolescents, and young key populations in particular. Click here to read the supplement.        

IAS announces plenary line-up for 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) 13 February 2015 (Geneva, Switzerland)—The International AIDS Society today announced the 12 plenary presentations that will lead the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) held in Vancouver, Canada from 19-22 July 2015. This year’s conference, hosted in partnership with the University of British Columbia Centre for Excellence in HIV/AIDS, is expec...

12 December 2014 (Geneva, Switzerland) – Today, The International AIDS Society (IAS) announced that Amsterdam, Netherlands will host the 22nd International AIDS Conference (AIDS 2018). AIDS 2018 will be held on 23-27 July 2018 at the Amsterdam RAI and is expected to bring together some 18,000 participants from around the world. “The Netherlands is a great example of what happens when a government supports outstanding science and embraces evidence-based HIV programmes in combination with a rob...

Collaboration to support advances in pediatric HIV treatment and care in low-resource settings 11 December 2014 (Geneva, Switzerland) - As part of its continued commitment to ending pediatric HIV globally, the International AIDS Society (IAS) today announced a new collaboration with Janssen, the pharmaceutical companies of Johnson & Johnson in the IAS Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) program. In support of CIPHER, Janssen is providing a grant to ac...